Blood Screening Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends

Top Countries — Revenue

USD Million/Billion
Loading…

Access the full forecast model.

Country-level data · Company profiles · Editable dataset · Analyst consultation included.

Blood Screening Market Analysis — Presence

Interactive World Map

Click countries to explore
Loading map…

Regional and Country Analysis

  • North America — United States, Canada, Mexico
  • Europe — United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe
  • Asia Pacific — China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC
  • South America — Brazil, Argentina, Colombia, Peru, Chile, Rest of South America
  • Middle East — Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East
  • Africa — East Africa, West Africa, North Africa, South Africa

Region / Country 2021 (A)2025 (A)2033 (P) CAGR

A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.

Unlock full regional dataset →

Segmentation Analysis

Market size by (Illustrative, 2025)
Share distribution (2025)

Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.

To learn more about market share and segmentation, request the free sample pages.

Blood Screening Market News

  • GRAIL has introduced Galleri, a groundbreaking multi-cancer early-detection blood test

In June 2021, GRAIL introduced the Galleri blood test, which is a multi-cancer early-detection blood test. The company announced Galleri is available in the U.S. by prescription only. This test will help the company screen around 50 million people after its launch and pursue a full FDA approval by 2023.

Click any bar or cell to request the full company profile
Company2022 (A)2023 (A)2024 (A)2025 (A)
Becton Dickinson••• ••• ••• •••
Abbott Laboratories••• ••• ••• •••
Thermo Fisher Scientific Inc.••• ••• ••• •••
Siemens AG••• ••• ••• •••
Ortho Clinical Diagnostics••• ••• ••• •••
Danaher Corporation••• ••• ••• •••
Bio-Rad Laboratories Inc.••• ••• ••• •••
F. Hoffmann-La Roche Ltd.••• ••• ••• •••
Grifols••• ••• ••• •••
Beckman Coulter Inc.••• ••• ••• •••

Revenue data requires full access. *2nd & 3rd tier companies available on enquiry.

Request company profile for validation →

Report Scope & Analysis

Global Blood Screening market size was USD 3.61 Billion in 2022 and it is forecasted to reach USD 5.14 Billion by 2030. Blood Screening Industry's Compound Annual Growth Rate will be 8.5% from 2023 to 2030.

Introduction of Blood Screening

Blood screening is the process of analyzing a sample of blood to assess various aspects of an individual's health. It involves the examination of blood components, such as red and white blood cells, platelets, and plasma, and the detection of specific biomarkers, antibodies, hormones, or other substances present in the blood. In addition, the blood screening test is the blood chemistry panel which includes various tests that assess the levels of different chemicals and substances in the blood. Furthermore, this screening helps to monitor diseases and prevent health issues and a variety of other conditions such as infections and cancer. Blood donor screening is the defense mechanism implemented against the spread of infection prior to blood donation.

Blood Screening Market Analysis Insights Video

Analyst Conclusion

Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.

The Blood Screening Market Analysis is witnessing significant growth in the near future.

In 2023, the Instruments segment accounted for a notable share of the Blood Screening Market Analysis.

Supriya Yadav
Supriya Yadav Verified Analyst
Research Analyst at Cognitive Market Research · Cognitive Market Research
LinkedIn Profile Book Appointment

Frequently Asked Questions

Blood Screening Market Analysis market size and growth rate is provided in the report covering 2021-2025 historical and 2025-2033 forecast data.
Major factors including drivers, restraints, opportunities and challenges are analyzed with detailed insights.
Top manufacturers Becton Dickinson, Abbott Laboratories, Thermo Fisher Scientific Inc., Siemens AG, Ortho Clinical Diagnostics, Danaher Corporation, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Grifols, Beckman Coulter Inc. and others are profiled in the report.
Segments include Product, End User and additional sub-segments.
Regional analysis covers all major markets. The report identifies the dominant region and provides country-level data.
Sample pages can be obtained on demand from the website. 24/7 chat support and direct call services are available.

★ Reviews

Rate this report

Blood Screening Market Analysis — Table of Contents

Disclaimer: Redacted sample for representative purposes. Charts and data do not depict actual statistics. TOC varies by license selection.
License Edition

Product Instruments, Software & Services, Reagents & Kits
End User Hospitals, Blood Banks
Technology Rapid Tests, Nucleic Acid Testing, Western Blot Assays, ELISA, Next Generation Sequencing
List of Competitors Becton Dickinson, Abbott Laboratories, Thermo Fisher Scientific Inc., Siemens AG, Ortho Clinical Diagnostics, Danaher Corporation, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Grifols, Beckman Coulter Inc.

  • 1.1 Global Power Realignment & Strategic Alliances
  • 1.2 Geopolitical Risk Landscape & Conflict Hotspots
  • 1.3 International Trade Relations & Market Access Environment
  • 1.4 Regulatory & Policy Shifts Impacting Cross-Border Operations
  • 1.5 Supply Chain Resilience, Localization & Resource Nationalism
  • 1.6 Technology Sovereignty & Digital Geopolitics
  • 1.7 Strategic Implications for Investment, Growth & Market Entry

  • 2.1 Competitive Landscape Disruption & Strategic Shifts
  • 2.2 AI-Driven Transformation of Industry Value Chain
  • 2.3 Evolution of Business Models & Revenue Streams
  • 2.4 Operational Efficiency & Cost Structure Transformation
  • 2.5 Product, Service & Innovation Acceleration
  • 2.6 Customer Behavior & Demand Evolution
  • 2.7 Future Outlook: AI-Led Market Evolution & Strategic Implications

  • 3.1 Global Blood Screening Revenue Market Size, Trend Analysis 2022 - 2034
  • 3.2 Global Blood Screening Volume Market Sales, Trend Analysis 2022 - 2034

  • Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.

    3.3 Global Blood Screening Market Size By Regions 2022 - 2034
    • 3.3.1 Global Blood Screening Revenue Market Size By Region
    • 3.3.2 Global Blood Screening Volume Market Sales By Region
  • 3.4 Global Blood Screening Market Size By Product 2022 - 2034
    • 3.4.1 Instruments Market Size
    • 3.4.2 Software & Services Market Size
    • 3.4.3 Reagents & Kits Market Size
  • 3.5 Global Blood Screening Volume Market Sales By Product 2022 - 2034
    • 3.5.1 Instruments Sales Volume
    • 3.5.2 Software & Services Sales Volume
    • 3.5.3 Reagents & Kits Sales Volume
  • 3.6 Global Blood Screening Market Size By End User 2022 - 2034
    • 3.6.1 Hospitals Market Size
    • 3.6.2 Blood Banks Market Size
  • 3.7 Global Blood Screening Volume Market Sales By End User 2022 - 2034
    • 3.7.1 Hospitals Sales Volume
    • 3.7.2 Blood Banks Sales Volume
  • 3.8 Global Blood Screening Market Size By Technology 2022 - 2034
    • 3.8.1 Rapid Tests Market Size
    • 3.8.2 Nucleic Acid Testing Market Size
    • 3.8.3 Western Blot Assays Market Size
    • 3.8.4 ELISA Market Size
    • 3.8.5 Next Generation Sequencing Market Size
  • 3.9 Global Blood Screening Volume Market Sales By Technology 2022 - 2034
    • 3.9.1 Rapid Tests Sales Volume
    • 3.9.2 Nucleic Acid Testing Sales Volume
    • 3.9.3 Western Blot Assays Sales Volume
    • 3.9.4 ELISA Sales Volume
    • 3.9.5 Next Generation Sequencing Sales Volume
  • 3.10 Global Level Competitor Analysis (Subject to Data Availability (Private Players))

  • You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)

    3.11 Executive Summary Global Market (2021 vs 2025 vs 2033)
    • 3.11.1 Regional Market Revenue Summary 2021 vs 2025 vs 2033
    • 3.11.2 Regional Volume Market Summary 2021 vs 2025 vs 2033
    • 3.11.3 Global Market Revenue Split By Product
    • 3.11.4 Global Volume Market Split By Product
    • 3.11.5 Global Market Revenue Split By End User
    • 3.11.6 Global Volume Market Split By End User
    • 3.11.7 Global Market Revenue Split By Technology
    • 3.11.8 Global Volume Market Split By Technology

    • Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable

      3.11.9 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities

  • 4.1 North America Blood Screening Market Outlook
    • 4.1.1 North America Blood Screening Market Size 2022 - 2034
    • 4.1.2 North America Blood Screening Volume Market Sales 2022 - 2034
    • 4.1.3 North America Blood Screening Market Size By Country 2022 - 2034
    • 4.1.4 North America Blood Screening Volume Market Sales By Country 2022 - 2034
    • 4.1.5 North America Blood Screening Market Size by Product 2022 - 2034
      • 4.1.5.1 North America Instruments Market Size
      • 4.1.5.2 North America Software & Services Market Size
      • 4.1.5.3 North America Reagents & Kits Market Size
    • 4.1.6 North America Blood Screening Volume Market Sales by Product 2022 - 2034
      • 4.1.6.1 North America Instruments Sales Volume
      • 4.1.6.2 North America Software & Services Sales Volume
      • 4.1.6.3 North America Reagents & Kits Sales Volume
    • 4.1.7 North America Blood Screening Market Size by End User 2022 - 2034
      • 4.1.7.1 North America Hospitals Market Size
      • 4.1.7.2 North America Blood Banks Market Size
    • 4.1.8 North America Blood Screening Volume Market Sales by End User 2022 - 2034
      • 4.1.8.1 North America Hospitals Sales Volume
      • 4.1.8.2 North America Blood Banks Sales Volume
    • 4.1.9 North America Blood Screening Market Size by Technology 2022 - 2034
      • 4.1.9.1 North America Rapid Tests Market Size
      • 4.1.9.2 North America Nucleic Acid Testing Market Size
      • 4.1.9.3 North America Western Blot Assays Market Size
      • 4.1.9.4 North America ELISA Market Size
      • 4.1.9.5 North America Next Generation Sequencing Market Size
    • 4.1.10 North America Blood Screening Volume Market Sales by Technology 2022 - 2034
      • 4.1.10.1 North America Rapid Tests Sales Volume
      • 4.1.10.2 North America Nucleic Acid Testing Sales Volume
      • 4.1.10.3 North America Western Blot Assays Sales Volume
      • 4.1.10.4 North America ELISA Sales Volume
      • 4.1.10.5 North America Next Generation Sequencing Sales Volume

  • 5.1 Europe Blood Screening Market Outlook
    • 5.1.1 Europe Blood Screening Market Size 2022 - 2034
    • 5.1.2 Europe Blood Screening Volume Market Sales 2022 - 2034
    • 5.1.3 Europe Blood Screening Market Size By Country 2022 - 2034
    • 5.1.4 Europe Blood Screening Volume Market Sales By Country 2022 - 2034
    • 5.1.5 Europe Blood Screening Market Size by Product 2022 - 2034
      • 5.1.5.1 Europe Instruments Market Size
      • 5.1.5.2 Europe Software & Services Market Size
      • 5.1.5.3 Europe Reagents & Kits Market Size
    • 5.1.6 Europe Blood Screening Volume Market Sales by Product 2022 - 2034
      • 5.1.6.1 Europe Instruments Sales Volume
      • 5.1.6.2 Europe Software & Services Sales Volume
      • 5.1.6.3 Europe Reagents & Kits Sales Volume
    • 5.1.7 Europe Blood Screening Market Size by End User 2022 - 2034
      • 5.1.7.1 Europe Hospitals Market Size
      • 5.1.7.2 Europe Blood Banks Market Size
    • 5.1.8 Europe Blood Screening Volume Market Sales by End User 2022 - 2034
      • 5.1.8.1 Europe Hospitals Sales Volume
      • 5.1.8.2 Europe Blood Banks Sales Volume
    • 5.1.9 Europe Blood Screening Market Size by Technology 2022 - 2034
      • 5.1.9.1 Europe Rapid Tests Market Size
      • 5.1.9.2 Europe Nucleic Acid Testing Market Size
      • 5.1.9.3 Europe Western Blot Assays Market Size
      • 5.1.9.4 Europe ELISA Market Size
      • 5.1.9.5 Europe Next Generation Sequencing Market Size
    • 5.1.10 Europe Blood Screening Volume Market Sales by Technology 2022 - 2034
      • 5.1.10.1 Europe Rapid Tests Sales Volume
      • 5.1.10.2 Europe Nucleic Acid Testing Sales Volume
      • 5.1.10.3 Europe Western Blot Assays Sales Volume
      • 5.1.10.4 Europe ELISA Sales Volume
      • 5.1.10.5 Europe Next Generation Sequencing Sales Volume

  • 6.1 Asia Pacific Blood Screening Market Outlook
    • 6.1.1 Asia Pacific Blood Screening Market Size 2022 - 2034
    • 6.1.2 Asia Pacific Blood Screening Volume Market Sales 2022 - 2034
    • 6.1.3 Asia Pacific Blood Screening Market Size By Country 2022 - 2034
    • 6.1.4 Asia Pacific Blood Screening Volume Market Sales By Country 2022 - 2034
    • 6.1.5 Asia Pacific Blood Screening Market Size by Product 2022 - 2034
      • 6.1.5.1 Asia Pacific Instruments Market Size
      • 6.1.5.2 Asia Pacific Software & Services Market Size
      • 6.1.5.3 Asia Pacific Reagents & Kits Market Size
    • 6.1.6 Asia Pacific Blood Screening Volume Market Sales by Product 2022 - 2034
      • 6.1.6.1 Asia Pacific Instruments Sales Volume
      • 6.1.6.2 Asia Pacific Software & Services Sales Volume
      • 6.1.6.3 Asia Pacific Reagents & Kits Sales Volume
    • 6.1.7 Asia Pacific Blood Screening Market Size by End User 2022 - 2034
      • 6.1.7.1 Asia Pacific Hospitals Market Size
      • 6.1.7.2 Asia Pacific Blood Banks Market Size
    • 6.1.8 Asia Pacific Blood Screening Volume Market Sales by End User 2022 - 2034
      • 6.1.8.1 Asia Pacific Hospitals Sales Volume
      • 6.1.8.2 Asia Pacific Blood Banks Sales Volume
    • 6.1.9 Asia Pacific Blood Screening Market Size by Technology 2022 - 2034
      • 6.1.9.1 Asia Pacific Rapid Tests Market Size
      • 6.1.9.2 Asia Pacific Nucleic Acid Testing Market Size
      • 6.1.9.3 Asia Pacific Western Blot Assays Market Size
      • 6.1.9.4 Asia Pacific ELISA Market Size
      • 6.1.9.5 Asia Pacific Next Generation Sequencing Market Size
    • 6.1.10 Asia Pacific Blood Screening Volume Market Sales by Technology 2022 - 2034
      • 6.1.10.1 Asia Pacific Rapid Tests Sales Volume
      • 6.1.10.2 Asia Pacific Nucleic Acid Testing Sales Volume
      • 6.1.10.3 Asia Pacific Western Blot Assays Sales Volume
      • 6.1.10.4 Asia Pacific ELISA Sales Volume
      • 6.1.10.5 Asia Pacific Next Generation Sequencing Sales Volume

  • 7.1 South America Blood Screening Market Outlook
    • 7.1.1 South America Blood Screening Market Size 2022 - 2034
    • 7.1.2 South America Blood Screening Volume Market Sales 2022 - 2034
    • 7.1.3 South America Blood Screening Market Size By Country 2022 - 2034
    • 7.1.4 South America Blood Screening Volume Market Sales By Country 2022 - 2034
    • 7.1.5 South America Blood Screening Market Size by Product 2022 - 2034
      • 7.1.5.1 South America Instruments Market Size
      • 7.1.5.2 South America Software & Services Market Size
      • 7.1.5.3 South America Reagents & Kits Market Size
    • 7.1.6 South America Blood Screening Volume Market Sales by Product 2022 - 2034
      • 7.1.6.1 South America Instruments Sales Volume
      • 7.1.6.2 South America Software & Services Sales Volume
      • 7.1.6.3 South America Reagents & Kits Sales Volume
    • 7.1.7 South America Blood Screening Market Size by End User 2022 - 2034
      • 7.1.7.1 South America Hospitals Market Size
      • 7.1.7.2 South America Blood Banks Market Size
    • 7.1.8 South America Blood Screening Volume Market Sales by End User 2022 - 2034
      • 7.1.8.1 South America Hospitals Sales Volume
      • 7.1.8.2 South America Blood Banks Sales Volume
    • 7.1.9 South America Blood Screening Market Size by Technology 2022 - 2034
      • 7.1.9.1 South America Rapid Tests Market Size
      • 7.1.9.2 South America Nucleic Acid Testing Market Size
      • 7.1.9.3 South America Western Blot Assays Market Size
      • 7.1.9.4 South America ELISA Market Size
      • 7.1.9.5 South America Next Generation Sequencing Market Size
    • 7.1.10 South America Blood Screening Volume Market Sales by Technology 2022 - 2034
      • 7.1.10.1 South America Rapid Tests Sales Volume
      • 7.1.10.2 South America Nucleic Acid Testing Sales Volume
      • 7.1.10.3 South America Western Blot Assays Sales Volume
      • 7.1.10.4 South America ELISA Sales Volume
      • 7.1.10.5 South America Next Generation Sequencing Sales Volume

  • 8.1 Middle East Blood Screening Market Outlook
    • 8.1.1 Middle East Blood Screening Market Size 2022 - 2034
    • 8.1.2 Middle East Blood Screening Volume Market Sales 2022 - 2034
    • 8.1.3 Middle East Blood Screening Market Size By Country 2022 - 2034
    • 8.1.4 Middle East Blood Screening Volume Market Sales By Country 2022 - 2034
    • 8.1.5 Middle East Blood Screening Market Size by Product 2022 - 2034
      • 8.1.5.1 Middle East Instruments Market Size
      • 8.1.5.2 Middle East Software & Services Market Size
      • 8.1.5.3 Middle East Reagents & Kits Market Size
    • 8.1.6 Middle East Blood Screening Volume Market Sales by Product 2022 - 2034
      • 8.1.6.1 Middle East Instruments Sales Volume
      • 8.1.6.2 Middle East Software & Services Sales Volume
      • 8.1.6.3 Middle East Reagents & Kits Sales Volume
    • 8.1.7 Middle East Blood Screening Market Size by End User 2022 - 2034
      • 8.1.7.1 Middle East Hospitals Market Size
      • 8.1.7.2 Middle East Blood Banks Market Size
    • 8.1.8 Middle East Blood Screening Volume Market Sales by End User 2022 - 2034
      • 8.1.8.1 Middle East Hospitals Sales Volume
      • 8.1.8.2 Middle East Blood Banks Sales Volume
    • 8.1.9 Middle East Blood Screening Market Size by Technology 2022 - 2034
      • 8.1.9.1 Middle East Rapid Tests Market Size
      • 8.1.9.2 Middle East Nucleic Acid Testing Market Size
      • 8.1.9.3 Middle East Western Blot Assays Market Size
      • 8.1.9.4 Middle East ELISA Market Size
      • 8.1.9.5 Middle East Next Generation Sequencing Market Size
    • 8.1.10 Middle East Blood Screening Volume Market Sales by Technology 2022 - 2034
      • 8.1.10.1 Middle East Rapid Tests Sales Volume
      • 8.1.10.2 Middle East Nucleic Acid Testing Sales Volume
      • 8.1.10.3 Middle East Western Blot Assays Sales Volume
      • 8.1.10.4 Middle East ELISA Sales Volume
      • 8.1.10.5 Middle East Next Generation Sequencing Sales Volume

  • 9.1 Africa Blood Screening Market Outlook
    • 9.1.1 Africa Blood Screening Market Size 2022 - 2034
    • 9.1.2 Africa Blood Screening Volume Market Sales 2022 - 2034
    • 9.1.3 Africa Blood Screening Market Size By Country 2022 - 2034
    • 9.1.4 Africa Blood Screening Volume Market Sales By Country 2022 - 2034
    • 9.1.5 Africa Blood Screening Market Size by Product 2022 - 2034
      • 9.1.5.1 Africa Instruments Market Size
      • 9.1.5.2 Africa Software & Services Market Size
      • 9.1.5.3 Africa Reagents & Kits Market Size
    • 9.1.6 Africa Blood Screening Volume Market Sales by Product 2022 - 2034
      • 9.1.6.1 Africa Instruments Sales Volume
      • 9.1.6.2 Africa Software & Services Sales Volume
      • 9.1.6.3 Africa Reagents & Kits Sales Volume
    • 9.1.7 Africa Blood Screening Market Size by End User 2022 - 2034
      • 9.1.7.1 Africa Hospitals Market Size
      • 9.1.7.2 Africa Blood Banks Market Size
    • 9.1.8 Africa Blood Screening Volume Market Sales by End User 2022 - 2034
      • 9.1.8.1 Africa Hospitals Sales Volume
      • 9.1.8.2 Africa Blood Banks Sales Volume
    • 9.1.9 Africa Blood Screening Market Size by Technology 2022 - 2034
      • 9.1.9.1 Africa Rapid Tests Market Size
      • 9.1.9.2 Africa Nucleic Acid Testing Market Size
      • 9.1.9.3 Africa Western Blot Assays Market Size
      • 9.1.9.4 Africa ELISA Market Size
      • 9.1.9.5 Africa Next Generation Sequencing Market Size
    • 9.1.10 Africa Blood Screening Volume Market Sales by Technology 2022 - 2034
      • 9.1.10.1 Africa Rapid Tests Sales Volume
      • 9.1.10.2 Africa Nucleic Acid Testing Sales Volume
      • 9.1.10.3 Africa Western Blot Assays Sales Volume
      • 9.1.10.4 Africa ELISA Sales Volume
      • 9.1.10.5 Africa Next Generation Sequencing Sales Volume

  • 10.1 Top Competitors Analysis

    • (Subject to Data Availability (Private Players))

      10.1.1 Global Blood Screening Market Revenue and Share by Key Players
    • 10.1.2 Global Blood Screening Market Volume and Share by Key Players
    • 10.1.3 Top Players Ranking 2024
    • 10.1.4 New Product Launch Analysis
    • 10.1.5 Industry Mergers and Acquisition Analysis
  • 10.2 Company Profile (Data Subject to Availability) Sample Format

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.1 Becton Dickinson
      • 10.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.1.2 Business Overview
      • 10.2.1.3 Financials (Subject to data availability)
      • 10.2.1.4 R&D Investment (Subject to data availability)
      • 10.2.1.5 Product Types Specification
      • 10.2.1.6 Business Strategy
      • 10.2.1.7 Recent Developments
      • 10.2.1.8 Management Change
      • 10.2.1.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.2 Abbott Laboratories
      • 10.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.2.2 Business Overview
      • 10.2.2.3 Financials (Subject to data availability)
      • 10.2.2.4 R&D Investment (Subject to data availability)
      • 10.2.2.5 Product Types Specification
      • 10.2.2.6 Business Strategy
      • 10.2.2.7 Recent Developments
      • 10.2.2.8 Management Change
      • 10.2.2.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.3 Thermo Fisher Scientific Inc.
      • 10.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.3.2 Business Overview
      • 10.2.3.3 Financials (Subject to data availability)
      • 10.2.3.4 R&D Investment (Subject to data availability)
      • 10.2.3.5 Product Types Specification
      • 10.2.3.6 Business Strategy
      • 10.2.3.7 Recent Developments
      • 10.2.3.8 Management Change
      • 10.2.3.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.4 Siemens AG
      • 10.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.4.2 Business Overview
      • 10.2.4.3 Financials (Subject to data availability)
      • 10.2.4.4 R&D Investment (Subject to data availability)
      • 10.2.4.5 Product Types Specification
      • 10.2.4.6 Business Strategy
      • 10.2.4.7 Recent Developments
      • 10.2.4.8 Management Change
      • 10.2.4.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.5 Ortho Clinical Diagnostics
      • 10.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.5.2 Business Overview
      • 10.2.5.3 Financials (Subject to data availability)
      • 10.2.5.4 R&D Investment (Subject to data availability)
      • 10.2.5.5 Product Types Specification
      • 10.2.5.6 Business Strategy
      • 10.2.5.7 Recent Developments
      • 10.2.5.8 Management Change
      • 10.2.5.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.6 Danaher Corporation
      • 10.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.6.2 Business Overview
      • 10.2.6.3 Financials (Subject to data availability)
      • 10.2.6.4 R&D Investment (Subject to data availability)
      • 10.2.6.5 Product Types Specification
      • 10.2.6.6 Business Strategy
      • 10.2.6.7 Recent Developments
      • 10.2.6.8 Management Change
      • 10.2.6.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.7 Bio-Rad Laboratories Inc.
      • 10.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.7.2 Business Overview
      • 10.2.7.3 Financials (Subject to data availability)
      • 10.2.7.4 R&D Investment (Subject to data availability)
      • 10.2.7.5 Product Types Specification
      • 10.2.7.6 Business Strategy
      • 10.2.7.7 Recent Developments
      • 10.2.7.8 Management Change
      • 10.2.7.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.8 F. Hoffmann-La Roche Ltd.
      • 10.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.8.2 Business Overview
      • 10.2.8.3 Financials (Subject to data availability)
      • 10.2.8.4 R&D Investment (Subject to data availability)
      • 10.2.8.5 Product Types Specification
      • 10.2.8.6 Business Strategy
      • 10.2.8.7 Recent Developments
      • 10.2.8.8 Management Change
      • 10.2.8.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.9 Grifols
      • 10.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.9.2 Business Overview
      • 10.2.9.3 Financials (Subject to data availability)
      • 10.2.9.4 R&D Investment (Subject to data availability)
      • 10.2.9.5 Product Types Specification
      • 10.2.9.6 Business Strategy
      • 10.2.9.7 Recent Developments
      • 10.2.9.8 Management Change
      • 10.2.9.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.10 Beckman Coulter Inc.
      • 10.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.10.2 Business Overview
      • 10.2.10.3 Financials (Subject to data availability)
      • 10.2.10.4 R&D Investment (Subject to data availability)
      • 10.2.10.5 Product Types Specification
      • 10.2.10.6 Business Strategy
      • 10.2.10.7 Recent Developments
      • 10.2.10.8 Management Change
      • 10.2.10.9 S.W.O.T Analysis

  • 11.1 Market Drivers
  • 11.2 Market Restraints
  • 11.3 Market Trends
  • 11.4 Market Opportunity
  • 11.5 Technological Road Map (Subject to Data Availability)
  • 11.6 Product Life Cycle (Subject to Data Availability)
  • 11.7 Customer and Buyer Behavior Analysis
    • 11.7.1 Consumer Demographics and Target Audience Assessment
    • 11.7.2 Consumer Purchase Behavior and Demand Assessment
    • 11.7.3 Consumer Pricing Dynamics and Affordability Assessment
    • 11.7.4 Digital Consumer Engagement and Online Adoption Analysis
    • 11.7.5 Future Consumption Trends and Demand Evolution Analysis
    • 11.7.6 Enterprise Procurement & Purchasing Behavior Analysis
    • 11.7.7 Buyer Decision-Making & Purchase Influence Assessment
    • 11.7.8 Customer Expectations & Service Experience Evaluation
    • 11.7.9 Vendor Selection & Supplier Preference Analysis
    • 11.7.10 Customer Retention & Loyalty Strategy Assessment
    • 11.7.11 Pricing Sensitivity & Value Perception Analysis
    • 11.7.12 Customer Segmentation & Demand Pattern Analysis
    • 11.7.13 Relationship Management & Strategic Partnership Trends
  • 11.8 Market Attractiveness Analysis
  • 11.9 PESTEL Analysis
    • 11.9.1 Political Factors
    • 11.9.2 Economic Factors
    • 11.9.3 Social Factors
    • 11.9.4 Technological Factors
    • 11.9.5 Legal Factors
    • 11.9.6 Environmental Factors
  • 11.10 Industrial Chain Analysis (Subject to Data Availability)
    • 11.10.1 Industry Chain Analysis
    • 11.10.2 Manufacturing Cost Analysis
    • 11.10.3 Supply Side Analysis
      • 11.10.3.1 Raw Material Analysis
      • 11.10.3.2 Raw Material Procurement Analysis
      • 11.10.3.3 Raw Material Price Trend Analysis
  • 11.11 Porter’s Five Forces Analysis
    • 11.11.1 Bargaining Power of Suppliers
    • 11.11.2 Bargaining Power of Buyers
    • 11.11.3 Threat of New Entrants
    • 11.11.4 Threat of Substitutes
    • 11.11.5 Degree of Competition
  • 11.12 Patent Analysis (Subject to Data Availability)
  • 11.13 ESG Analysis

  • 12.1 Instruments
    • 12.1.1 Global Blood Screening Revenue Market Size and Share by Instruments 2022 - 2034
    • 12.1.2 Global Blood Screening Volume Market Sales by Instruments 2022 - 2034
  • 12.2 Software & Services
    • 12.2.1 Global Blood Screening Revenue Market Size and Share by Software & Services 2022 - 2034
    • 12.2.2 Global Blood Screening Volume Market Sales by Software & Services 2022 - 2034
  • 12.3 Reagents & Kits
    • 12.3.1 Global Blood Screening Revenue Market Size and Share by Reagents & Kits 2022 - 2034
    • 12.3.2 Global Blood Screening Volume Market Sales by Reagents & Kits 2022 - 2034

  • 13.1 Hospitals
    • 13.1.1 Global Blood Screening Revenue Market Size and Share by Hospitals 2022 - 2034
    • 13.1.2 Global Blood Screening Volume Market Sales by Hospitals 2022 - 2034
  • 13.2 Blood Banks
    • 13.2.1 Global Blood Screening Revenue Market Size and Share by Blood Banks 2022 - 2034
    • 13.2.2 Global Blood Screening Volume Market Sales by Blood Banks 2022 - 2034

  • 14.1 Rapid Tests
    • 14.1.1 Global Blood Screening Revenue Market Size and Share by Rapid Tests 2022 - 2034
    • 14.1.2 Global Blood Screening Volume Market Sales by Rapid Tests 2022 - 2034
  • 14.2 Nucleic Acid Testing
    • 14.2.1 Global Blood Screening Revenue Market Size and Share by Nucleic Acid Testing 2022 - 2034
    • 14.2.2 Global Blood Screening Volume Market Sales by Nucleic Acid Testing 2022 - 2034
  • 14.3 Western Blot Assays
    • 14.3.1 Global Blood Screening Revenue Market Size and Share by Western Blot Assays 2022 - 2034
    • 14.3.2 Global Blood Screening Volume Market Sales by Western Blot Assays 2022 - 2034
  • 14.4 ELISA
    • 14.4.1 Global Blood Screening Revenue Market Size and Share by ELISA 2022 - 2034
    • 14.4.2 Global Blood Screening Volume Market Sales by ELISA 2022 - 2034
  • 14.5 Next Generation Sequencing
    • 14.5.1 Global Blood Screening Revenue Market Size and Share by Next Generation Sequencing 2022 - 2034
    • 14.5.2 Global Blood Screening Volume Market Sales by Next Generation Sequencing 2022 - 2034

  • 15.1 Company Gap Assessment Analysis
  • 15.2 Product & Service Portfolio Gap Analysis
  • 15.3 Demand-Supply Imbalance Analysis
  • 15.4 Market Opportunity & Unmet Needs Analysis
  • 15.5 Technology Adoption & Digital Transformation Gap Analysis
  • 15.6 Operational Efficiency & Process Gap Analysis
  • 15.7 Infrastructure & Capacity Gap Analysis
  • 15.8 Geographic Coverage & Distribution Gap Analysis
  • 15.9 Investment Opportunity & Funding Gap Analysis
  • 15.10 Pricing Structure & Margin Gap Analysis
  • 15.11 Innovation & R&D Capability Gap Analysis
  • 15.12 Policy, Compliance & Regulatory Gap Analysis
  • 15.13 Customer Experience & Expectation Gap Analysis
  • 15.14 Future Growth Opportunity Gap Analysis
  • 15.15 Market Accessibility & Penetration Gap Analysis

  • 16.1 Gross Margin Overview and Industry Profitability Trends
  • 16.2 Regional Gross Margin Performance Analysis
  • 16.3 Supply Chain and Distribution Impact on Gross Margins
  • 16.4 Pricing Strategy and Value-Added Margin Assessment
  • 16.5 Key Factors Influencing Gross Margin Variability
  • 16.6 Future Gross Margin Outlook and Profitability Trends

  • 17.1 Key Takeaways

  • Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.

    17.2 Analyst Point of View
  • 17.3 Assumptions and Acronyms

  • 18.1 Primary Data Collection
    • 18.1.1 Steps for Primary Data Collection
      • 18.1.1.1 Identification of KOL
    • 18.1.2 Backward Integration
    • 18.1.3 Forward Integration
    • 18.1.4 How Primary Research Help Us
    • 18.1.5 Modes of Primary Research
  • 18.2 Secondary Research
    • 18.2.1 How Secondary Research Help Us
    • 18.2.2 Sources of Secondary Research
  • 18.3 Data Validation
    • 18.3.1 Data Triangulation
    • 18.3.2 Top Down & Bottom Up Approach
    • 18.3.3 Cross check KOL Responses with Secondary Data
  • 18.4 Data Representation

Athenaeum AI Dashboard

Research Framework · 70:30 Primary:Secondary

Our Proprietary Methodology

Cognitive Market Research employs "The Full Truth™" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Blood Screening Market Analysis Market analysis.

01

Primary Intelligence Gathering

Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.

02

Secondary Data Triangulation

Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.

03

Expert Validation Protocol

Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.

04

Athenaeum AI Processing

Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.

05

Editorial & QA Review

Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.

Data Assurance Metrics
Data Points Validated 10,400+
Expert Interviews 54
Countries Covered 39+
Company Profiles 10+
Forecast Accuracy (Historical) 94.2%
Report Pages 250+
Analytical Coverage
Market Sizing Revenue Forecast CAGR Analysis Competitor Benchmarking SWOT Porter's Analysis PESTEL Value Chain ESG Analysis Tariff Impact Patent Mapping Tech Trends

To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.

Latest News about Blood Screening Market

Sources from Medical Devices & Consumables Industry

How We Serve You

Three Pillars of Market Intelligence

We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Blood Screening Market Analysis market.

Service 01

Market Survey

B2B B2C

Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the blood screening market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.

What's Included
  • Buyer intent & sentiment analysis
  • Purchase cycle mapping
  • Price sensitivity research
  • Channel preference profiling
  • Competitive perception study
Most Requested
Service 02

Customized Market Data & Reports

Custom Ready Report

Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.

What's Included
  • Ready syndicate report (250+ pages)
  • Custom data scope & segmentation
  • Excel quantitative models
  • Board-ready PPT with key findings
  • Secure cloud portal access
Service 03

Strategic Consultation

With Survey With Report

Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.

What's Included
  • Dedicated analyst assigned to you
  • Live walkthrough of findings
  • Strategic Q&A sessions
  • Go-to-market recommendations
  • NDA-protected engagement

Customize This Report

Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.

Blood Screening market size was USD 3.61 Billion in 2022!